🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Two weeks to #ESMO24. Multiple important breast onc trials readouts across disease subtypes, including OS from KN522, DB12, 4y of NATALEE, CAPItello290, phase 1 studies of novel ADCs, IO, targeted drugs, and so much more. The countdown is on. See you soon in Barcelona! 🇪🇸 #bcsm

FDA Approves Ribociclib With an Aromatase Inhibitor in Early Breast Cancer. This is for stage 2 and 3 breast cancer at high risk for recurrence, that includes node negative disease. #bcsm ⁦OncoAlert⁩ targetedonc.com/view/fda-appro…

This is a picture of hope. The ⁦The Breast Cancer Research Foundation⁩ funded researchers working to end breast cancer. I am living proof of their work. Thank you!!!

Honored to be on the ballot for the Designated Community Oncology seat. ASCO has done a remarkable job of selecting a lineup of brilliant candidates. I personally have SO MUCH respect for each one of them! Your voice counts, please vote. asco.org/election ASCO Eric J. Small, MD, FASCO

Honored/humbled to be a candidate for ASCO nominating committee after serving in several committees, leadership development program, etc. There are excellent candidates in all categories! We encourage active members to vote & help shape future of ASCO society.asco.org/about-asco/asc…

Join us in Hawaii (or via livestream) Feb. 3-7, 2025 for the Mayo Clinic Hematology & Medical Oncology Practice Updates & Board Review! Mayo Clinic Hematology-Oncology Fellowship Mayo Clinic Thor Halfdanarson Rami Manochakian MD, FASCO Cancer Education Register here: tinyurl.com/yp7n2ac6

Join us in Hawaii (or via livestream) on Feb. 3-7 for Heme & Med Oncology Updates & Board Review 2025! Our outstanding hem/onc faculty will cover updates on best practices, new developments in the field, & board prep. Register here: tinyurl.com/yp7n2ac6 ce.mayo.edu/hematology-and…

Epic Fail... it is the holiday season and you decide to gift your mentor a fancy bottle of scotch. Days later, the surgeon general launches a campaign informing alcohol increases the risk of cancer. #Ididnotmeanit #Ihonestlylikemymentor

Masterclass presentation on the management of advanced colorectal cancer from Tanios Bekaii-Saab, MD at the inaugural Mayo Clinic Heme/Onc Board Review and Practice Update conference this week. Can he fit it in one slide...? He sure can! Don't miss this next year. tinyurl.com/rh7c927c

.Hope Rugo’s talk presents many controversies for the consensus panel to explore RE: eTNBC— 🎯 should we routinely report TILS? How? What is High v. Low? 🎯should pts w/High TILs receive less chemo? None? At what stage? 🎯 At what tumor size should chemo be given? #SGBCC2025

Episode 3 of Empowering Oncologists: Dr. Jasmine Kamboj sits down with Dr. Mark Walshauser to tackle a question many oncologists face: How do I balance research and leadership while pursuing the partnership track? Jasmine Kamboj, MD, FASCO @WalshauserMD x.com/i/broadcasts/1…

If you are in the twin cities, join us in this OncLive Breast Cancer State if the science Summit April 10 at 6 PM!

Hear from experts and advocates on the latest in #TNBC diagnosis, treatment, and research in our new webinar. Thank you to Gilead Oncology for making this program possible. Watch now 🎥 bit.ly/3FW0QeS #BreastCancerAwareness #CancerResearch #BreastCancer

Residual Cancer After Neoadjuvant Chemo May Exhibit Higher ER Expression Compared With Pretreatment Tumor in ER-Negative or ER-Low Breast Cancer dailynews.ascopubs.org/do/residual-ca… @asco #asco25 @glopesmd

Is liquid biopsy useful in bone-only metastatic #breastcancer? Surprise! ✅Pts w bone-only disease are just as likely to have detectable ctDNA ✅ctDNA tumor fraction remains prognostic in bone-only setting link.springer.com/article/10.100… Foundation Medicine The James Ohio State Medical Oncology

Building off of Nancy Lin, MD and Dr Pablo Leone’s data with carboplatin/bevacizumab in brain metastases. 77% intracranial response rate of carbo, bev, and PD-1 inhibition in TNBC brain metastases shows excellent potential. Time to try this with bispecifics. #bcsm #ASCO25

So proud of this Star 🌟! You're going to be seeing more of Dr. Sarah Premji #bcsm community! #ASCO25 Sarah Premji, MD Dee Anna Smith David R. Spigel, MD, FASCO SCRI Oncology Partners Sarah Cannon Docs

Frank Sinicrope, MD of Mayo Clinic Comprehensive Cancer Center Mayo Clinic presenting results of ATOMIC trial at ASCO #asco25 #plenary. Proud of our colleague!

Recent rationale in metastatic breast cancer for bringing ADCs into the 1st line has quoted very high 1st line attrition rates of patients not making it to second line. This study is likely more accurate of 2025 patients. In total, 9% of patients with MBC do not make it to

Want a quick update in medical oncology on July 19 (with some heme updates in the mix)...? If so, we have the course for you! I can promise excellent content/speakers and there is a livestream (virtual) option too for those who cannot attend in person. ce.mayo.edu/hematology-and…